Therapy of advanced gastrointestinal cancer with the nitrosoureas.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002330:Carmustine / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D003110:Colonic Neoplasms / Q000188:drug therapy; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007958:Leukocyte Count; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D012004:Rectal Neoplasms / Q000188:drug therapy; D013997:Time Factors
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009607:Nitrosourea Compounds; D005472:Fluorouracil; D002330:Carmustine